| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $44.56B | $42.88B | $42.86B |
| YoY Revenue Growth % | +3.9% | +0.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $7.75B | $7.34B | $6.86B |
| Operating Margin % | 17.4% | 17.1% | 16.0% |
| Net Income (GAAP) | $6.72B | $6.34B | $5.96B |
| EBITDA (Normalized) | $8.97B | $8.46B | $8.40B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.82B | $8.67B | $8.41B |
| Capital Expenditures (CapEx) | $1.52B | $1.40B | $1.93B |
| Free Cash Flow (FCF) | $6.29B | $7.27B | $6.48B |
| FCF Margin % | 14.1% | 16.9% | 15.1% |
| Return on Invested Capital (ROIC %) | 8.8% | 8.5% | 6.2% |
| Cash & Short-Term Equivalents | $9.85B | $4.01B | — |
| Total Debt (Short + Long Term) | $25.82B | $22.77B | $33.75B |
| Total Stockholders' Equity | $53.41B | $49.58B | $69.23B |